Screening to avoid the morbidity and mortality of colorectal cancer (CRC) in patients with CF, with the incidence of CRC rising, has become an increasingly important challenge, particularly among lung transplant patients.  But how and when should patients be screened? With colonoscopy or non-invasive FIT? Before or after transplant?  Are there patients who should not be screened, and why?

In this issue, Dr. Denis Hadjiliadis from the Perelman School of Medicine at the University of Pennsylvania discusses the clinical aspects of screening patients with CF to prevent CRC.

Take our post-test to claim CME credits.

To read a companion newsletter click here.

Hosted on Acast. See acast.com/privacy for more information.